Janssen Inc: Biologics Savings Partnership Presentation

Biologics Savings Partnership by Chris Fearman of Janssen Inc.

Chris goes into detail regarding the difference between biologic and biosimilar drugs as well as what is considered a chronic immunological disease and failure of treatment options. To learn more and enjoy the rest of the presentation, please follow the link below.

Download the full presentation here